Ann: Annual Report to shareholders, page-11

3/4 should be a fair assumptions $10m is also the minimum order so we could see a larger number in FY21 as you pointed.. add order from other customers and things start looking pretty sizable.

BCT made the decision to nail their relationship and orders from Labcon this year to make it their flagship and the results are there for anyone to see. In less than 18 months they went from a general MOU to multi-year orders.

Scalability has been done carefully from what I gathered from 5k to 50k to nearly 100k per month. Their manufacturing partner has very large facilities and the manufacture itself is not a bottleneck. It's the testing done by BCT prior to shipping to Labcon that BCT has been perfecting and automating since the start of the year. Quality first.

Since they have scaled up by over 20x in the last 9 months (from sub 5x to around 100kpm), then to go from 100k to 700k over 24 months should be straight forward.

Good times ahead. Agree that the valuation should be near or above $100m versus the sad sub $30m, but the potential can only be ignored for so long.... with the BS in top shape, there is nothing holding it back now..